procedure

The European Securities and Markets Authority (ESMA) has issued a public statement regarding the investor protection concerns raised by derivatives on fractions of shares.
The statement discusses the rise of online investment firms known as „neo-brokers“ that operate exclusively through websites and apps, often offering fractional investing in multiple EU countries under the MiFID Directive. Fractional investing allows investors to determine the amount they wish to invest in a share, making expensive shares more accessible and portfolio diversification easier.
However, investors should be aware that they are not investing in the share itself but in another investment instrument, which may carry different risks and costs.
In fractional investing via derivatives, the investor acquires a debt claim that reflects a portion of the financial value of the underlying share, with no voting rights, and is not transferable to other investors.
There are risks associated with fractional investing, such as counterparty risk and liquidity risk. In fractional investing via derivatives, investors are exposed to the risk that the counterparty may become insolvent, and there may be operational difficulties accessing fractions if a financial institution involved in the structuring runs into financial difficulty.
Fractional investing can also incur additional costs, such as bid-offer spread differences and varying commissions. Investors should be cautious of these costs, especially as the amount involved in fractional investing may be very slight. Therefore, transparency is essential, and investors should be aware of the structure and characteristics of the fractional shares they invest in.
ESMA highlights that derivatives on fractions of shares are not corporate shares and that firms should not use the term fractional shares when referring to these instruments. In line with the obligation to make clients reasonably able to understand the nature and risks of the specific type of financial instrument, firms should make clear to the investor that they are buying a derivative instrument. ESMA reminds firms that all information provided to clients on these instruments shall be fair, clear, and not misleading, and that firms must clearly disclose all direct and indirect costs and charges relating to them. Additionally, as derivatives are complex products, they are expected to result in a narrow target market of clients, and an appropriateness assessment needs to be carried out where non-advised services are provided. ESMA notes that these clarifications may also be relevant to fractional investing through other structures such as co-ownership. The statement also reminds companies offering derivatives on fractions of shares of their obligation under the PRIIPs Regulation to provide a key information document.

Other Features
assessment
best execution
broker
companies
counterparty
Derivatives
disclosure
fees
governance
insolvency
investment firms
investor protection
issuer
liquidity
marketing
operational
product governance
prospectus
retail investors
risk
sales documents
securities
shareholders
surveys
transparency
Date Published: 2023-03-28
Regulatory Framework: Markets in Financial Instruments Directive II (MiFID II), Packaged Retail and Insurance-based Investment Products Regulation (PRIIPs Regulation)
Regulatory Type: procedure

[JC 2023 82 ] List of Financial Conglomerates 2023

ID 26470
The three European Supervisory Authorities (ESAs) have published a revised list of firms c ...

ESMA consults on possible changes to the securitisation disclosure templates

ID 26449
ESMA has initiated a consultation on potential changes to the securitisation disclosure te ...

ESAs propose extending the EMIR equity option exemption

ID 26434
The ESAs have proposed a two-year extension to the equity option exemption from bilateral ...

[ESMA84-2037069784-2106 ] Report on CRA Market Share Calculation 2023

ID 26412
In order to enhance market competition among credit rating agencies (CRA) and to foster th ...
  • Topic Filter

    Top Tag Search
    Top Tag Search
    Top Tag Search
    Top Tag Search
You are on the training version of RISP core with limited functions and data. Please subscribe to RISP core for professional or academic use. We supply free real time datasets for approved academic research; professional subscriptions start at 950€ plus VAT per annum.

Compare Listings